BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lambrinoudaki I, Armeni E, Goulis D, Bretz S, Ceausu I, Durmusoglu F, Erkkola R, Fistonic I, Gambacciani M, Geukes M, Hamoda H, Hartley C, Hirschberg AL, Meczekalski B, Mendoza N, Mueck A, Smetnik A, Stute P, van Trotsenburg M, Rees M. Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society. Maturitas 2022;163:1-14. [DOI: 10.1016/j.maturitas.2022.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nappi RE. The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news. The Lancet Diabetes & Endocrinology 2022;10:832-834. [DOI: 10.1016/s2213-8587(22)00285-6] [Reference Citation Analysis]
2 Stefanowski B, Kucharski M, Szeliga A, Snopek M, Kostrzak A, Smolarczyk R, Maciejewska-jeske M, Duszewska A, Niwczyk O, Drozd S, Englert-golon M, Smolarczyk K, Meczekalski B. Cognitive decline and dementia in women after menopause: Prevention strategies. Maturitas 2022. [DOI: 10.1016/j.maturitas.2022.10.012] [Reference Citation Analysis]
3 Armeni E, Mili N, Siliogka E, Goulis DG, Lambrinoudaki I. Menopause medical education around the world: The way forward to serve women's health. Current Opinion in Endocrine and Metabolic Research 2022;26:100387. [DOI: 10.1016/j.coemr.2022.100387] [Reference Citation Analysis]
4 Gambacciani M, Cagnacci A. HRT in a new light: Thanks UK. Maturitas 2022;164:98-9. [PMID: 36027841 DOI: 10.1016/j.maturitas.2022.08.004] [Reference Citation Analysis]
5 Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-capilla A, Sánchez-borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group. Maturitas 2022. [DOI: 10.1016/j.maturitas.2022.08.008] [Reference Citation Analysis]